Biotech stocks have plenty of catalysts around the corner By: MarketWatch September 30, 2016 at 05:14 AM EDT While buyouts are looming, political bashing of drug prices has died down, says Michael Brush. Read More >> Related Stocks: Acadia Pharmaceutica Alkermes Plc Allergan Plc Amgen Biogen Idec Biomarin Pharmaceuticals Bluebird Bio Bristol-Myers Squibb Celgene Corp Eli Lilly Gilead Sciences Incyte Corp Intercept Pharmaceuticals Johnson & Johnson Merck & Co Neurocrine Bioscienc Ophthotech Corp Pfizer Roche Holding AG Basel American Depositary Shares Sarepta Therapeutics Takeda Pharma Teva Pharmaceutical Industries ADR Vertex Pharmaceuticals